Home » GSK Sells Australian Drugs to Aspen for $423 million
GSK Sells Australian Drugs to Aspen for $423 million
GlaxoSmithKline advanced its clear-out of non-core drugs on Wednesday with a deal to sell 25 older brands marketed in Australia to South Africa’s Aspen Pharmacare for $423 million.
Yahoo! News
Yahoo! News
Upcoming Events
-
28Mar
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May